MedPath

A prospective observational study of lung microbiome in pulmonary diseases

Not Applicable
Conditions
pulmonary diseases
Registration Number
JPRN-UMIN000022428
Lead Sponsor
Sapporo Medical University
Brief Summary

Impaired diversity of the lung microbiome predicts progression of idiopathic pulmonary fibrosis.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
130
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who are difficult to examine the lower airway.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
We identify the specific microbiome pattern from patients' bronchoalveolar lavage fluid.
Secondary Outcome Measures
NameTimeMethod
We study the relationship between microbiome and patients' labo data (WBC, SP-A and SP-D).
© Copyright 2025. All Rights Reserved by MedPath